Journal of Immune Based Therapies, Vaccines and Antimicrobials
Vol.1 No.2(2012), Paper ID 21264, 5
pages
DOI:10.4236/jibtva.2012.12003
Telavancin in Experimental Murine Pneumococcal Pneumonia
Suzannah M. Schmidt, Melissa J. Karau, Jayawant N. Mandrekar, James M. Steckelberg, Robin Patel
Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Rochester, US
Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Rochester, US
Department of Health Sciences Research Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, US
Department of Medicine, Division of Infectious Diseases, Rochester, US
Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Rochester, US
Copyright © 2012 Suzannah M. Schmidt, Melissa J. Karau, Jayawant N. Mandrekar, James M. Steckelberg, Robin Patel et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
S. Schmidt, M. Karau, J. Mandrekar, J. Steckelberg and R. Patel, "Telavancin in Experimental Murine Pneumococcal Pneumonia,"
Journal of Immune Based Therapies, Vaccines and Antimicrobials, Vol. 1 No. 2, 2012, pp. 15-19. doi:
10.4236/jibtva.2012.12003.